Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

SHARx Warns: The Pharmacy Budget Trap — Why Discounts Alone Cannot Control Total Spending

Growth Officer and Co-Founder of SHARx, a procurement management solution for high-cost prescription drugs. Demand for GLP-1 medications, specialty drugs and other high-cost therapies is reshaping benefits budgets. Employers often judge pharmacy...

Aptar Pharma Launched Premia™ Precision, Establishing a New Quality Standard for Demanding Injectable Therapies

manufacturers advance their quality and regulatory objectives. As injectable therapies, including biologics and GLP-1 therapies, become increasingly complex and valuable, expectations for primary packaging components are evolving beyond baseline...

Ro and Novo announce research collaboration to generate first-of-its-kind real-world evidence on the Wegovy® pill

presented on September 30 at EASD2026 in Milan, IT, evaluated outcomes among patients who switched from an injectable GLP-1 to the Wegovy® pill on Ro's platform. Ro is the leading provider of GLP-1s in the country. Since April 2025, Ro has worked...

Jarrow Formulas® Launches Gut & Protein Optimizer and NMN 300 mg to Support Protein Absorption, Cellular Energy, and Healthy Aging

consume.* Jarrow Gut & Protein Optimizer is great for those prioritizing their protein intake, including those using GLP-1s.* The product's formula combines Mycosha™, a clinically studied probiotic shown to support protein absorption and a healthy...

Choose Health Launches Comprehensive At-Home Liver Function Test Featuring 20+ Biomarkers and Clinical Risk Scores

"We've been focused on liver health since 2018 because we saw this epidemic coming," said Holland. "With the rise of GLP-1 medications and awareness of metabolic health, now is the moment for consumers to take liver health as seriously as...

EMS and BD expand access to GLP-1 therapies in Brazil by launching semaglutide.

ongoing healthcare challenges associated with chronic diseases, including obesity and type 2 diabetes. Global demand for GLP‑1 therapies has highlighted the critical need for delivery systems that enable safe, accurate, and consistent dosing for...

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

Starting today FDA-approved Wegovy® (semaglutide) is available through the Medicare GLP-1 Bridge, a new access pathway for millions of older adults living with obesity. Obesity is a serious, common chronic disease among older Americans and Wegovy®...

Roquette Highlights Scalable Innovations in Drug Delivery

promising formulations into scalable commercial realities. “As the pharmaceutical industry accelerates innovation, from GLP-1 therapies to complex biologics, the pressure to deliver manufacturing reliability, consistent supply, and robust...

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

and already feature in a full spectrum of supplement formulations targeting healthy ageing, sports and active nutrition, GLP-1 support, and cellular health," adds Gutiérrez Montero. A central mechanism of TetraSOD®'s action, highlighted in multiple...

MinuteClinic highlights improved access and outcomes through its clinically supervised weight-loss program

treatment plans. When clinically appropriate, providers may prescribe FDA-approved weight-loss medications, including GLP-1 therapies, alongside ongoing nutrition counseling and lifestyle coaching1. With about 74% of U.S. adults meeting criteria...

Amazon Pharmacy Expands Same-Day Delivery and Kiosk Access for New Ozempic® Pill

medications directly to customers' homes, is expanding access to Novo Nordisk's Ozempic® pill, the only FDA-approved oral GLP-1 medication to treat type 2 diabetes. Amazon Pharmacy will offer Same-Day prescription delivery and pickup within minutes...

Novo Nordisk’s Ozempic pill—the only FDA-approved oral peptide GLP-1 for adults with Type 2 Diabetes—will soon be available in the U.S

4 mg, and 9 mg will be available for adults with type 2 diabetes in the US. Ozempic® is the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabete. Indicated not only to improve blood sugar, along with diet and exercise, but...

Ascletis announces completion of enrollment in its U.S. Phase II study evaluating ASC30, an oral small-molecule GLP-1R agonist, for diabetes treatment

completion of enrollment in its 13-week U.S. Phase II study (NCT07321678) evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist, for the treatment of type 2 diabetes mellitus (T2D). T2D is the second indication for ASC30,...

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

healthcare company, announced eligible patients can now access Foundayo™ (orforglipron) – Eli Lilly Company's newest oral GLP-1 innovation – on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s. Foundayo™ is a...

CoreAge Rx broadens GLP-1 access in support of New Year weight loss initiatives

pharmacy specializing in personalized medication services, announced a strategic New Year's expansion of its compounded GLP-1 weight management program. The expansion provides increased access to compounded tirzepatide and semaglutide, perfectly...

PureWay and PPSWG Form New Partnership to Transform Pharmaceutical Waste Management in the U.S.

waste management. Millions of Americans rely on self-administered injectable medications every day, including insulin, GLP-1 therapies, migraine biologics, and autoimmune biologics. The resulting waste (billions of discarded needles and syringes)...

2025 Interim Results and Business Updates Announced by Innovent

antibody, ending a 70-year drought of no new treatment options for thyroid eye disease (TED) in China Mazdutide (GCG/GLP-1) : Globally first and only GCG/GLP-1 dual receptor agonist for weight management, with another NDA for glycemic control of...

GoodRx has announced a collaboration with Novo Nordisk to offer expanded access to Ozempic® and Wegovy® for $499 per month

effective today. This collaboration significantly lowers the price available on GoodRx for two of the most in-demand GLP-1 medications nationwide, expanding access for those who lack adequate insurance coverage. Today also marks the first time...

Proving the strength of its drug-delivery platform, the Daewoong Therapeutics Microneedle Patch achieves best-in-class bioavailability

in 2024 and is projected to grow to 60.5 billion US dollars by 2030. Currently, therapeutic and safety advantages in the GLP-1 drug class are limited, and experts expect Experts expect delivery technologies improving both bioavailability and...

Get visibly lifted with SkinCeuticals' newest lifting solution, A.G.E. Interruptor Ultra Serum for your face

and Cream with an ultrasound procedure delivers -20% skin laxity vs. control in 12 weeks and is physician-tested with GLP-1 patients. "I've seen a marked increase in patients experiencing skin laxity, and they are looking for effective,...

Results 1 - 20 of 30